Technology | Angiography
Canon Medical Systems USA recently introduced its next generation of interventional systems – the Alphenix platform. The new flagship platform of systems incorporates all-new features that enable clinicians to deliver images with clarity and precision without compromising workflow and while prioritizing low dose.Canon Medical Systems USA recently introduced its next generation of interventional systems – the Alphenix platform. The new flagship platform of systems incorporates all-new features that enable clinicians to deliver images with clarity and precision without compromising workflow and while prioritizing low dose.Canon Medical Systems USA recently introduced its next generation of interventional systems – the Alphenix platform. The new flagship platform of systems incorporates all-new features that enable clinicians to deliver images with clarity and precision without compromising workflow and while prioritizing low dose.
February 04, 2019 
Blog | Cybersecurity
Cyber hackers pose a worsening threat to radiology and the rest of medical imaging. This risk might be reduced, however ...
February 04, 2019 
Podcast | Cybersecurity
Cyber hackers pose a worsening threat to radiology and the rest of medical imaging. This risk might be reduced, however ...
February 04, 2019 Sponsored Content
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
September 25, 2024 
News | Proton Therapy
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (The University of Oklahoma) Medicine has commenced proton therapy treatments with the Mevion S250i Proton Therapy System with Hyperscan Pencil Beam Scanning. Cleared by the U.S. Food and Drug Administration (FDA) in 2017, Hyperscan improves on existing scanning capabilities to deliver conformal fields of therapeutic radiation to tumors faster with more precision.
February 01, 2019 
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos, based on data collected from 330 patient scans.
February 01, 2019 Sponsored Content
News | Computed Tomography (CT) | August 06, 2024
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
News | Artificial Intelligence
The European Society of Radiology (ESR) and GE Healthcare are partnering on artificial intelligence (AI) for the upcoming European Congress of Radiology (ECR), Feb. 27-March 3, 2019 in Vienna, Austria. The partnership includes joint sessions on artificial intelligence and a 300 m² dedicated space on GE Healthcare’s 850 m² booth where visitors can experience the AI transformation through interactive tools.
February 01, 2019 Sponsored Content
News | Computed Tomography (CT)
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
August 06, 2024 
News | Digital Pathology
February 1, 2019 — The world market for digital pathology, comprising whole slide scanner hardware, software and ...
February 01, 2019 
Feature | A.J. Connell and Dave Fornell
February 1, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine website ...
February 01, 2019 
Sponsored Content | Videos | Artificial Intelligence
Artificial intelligence can do more than assist in the interpretation of patient images. At RSNA 2018, Imalogix showed ...
February 01, 2019 Sponsored Content
News | Artificial Intelligence
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
June 21, 2024 
Technology | Breast Density
Volpara Solutions Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for new technologies used in the Volpara Density clinical application for breast density assessment. The updated version of VolparaDensity more accurately reflects breast density from images captured using the Hologic SmartCurve system.
January 31, 2019 
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life. The study is published in the January issue of International Journal of Radiation Oncology • Biology • Physics (Red Journal).
January 31, 2019 
News | Ultrasound Imaging
Konica Minolta Healthcare Americas Inc. released a new software upgrade for the Sonimage HS1 Ultrasound System that delivers workflow improvements, new imaging capabilities and artificial intelligence-assisted functionality for hands-free operation during interventional procedures. Designed with the musculoskeletal (MSK) practitioner in mind, the HS1 System features advanced functionality to support confident diagnoses and treatment management at the point of care.
January 31, 2019 Sponsored Content
Feature | Artificial Intelligence
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
June 03, 2024 
News | Treatment Planning
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc. to improve ...
January 31, 2019 
News | Artificial Intelligence
January 30, 2019 – The Radiological Society of North America (RSNA) published the first issue of its new online journal ...
January 30, 2019 Sponsored Content
News | Artificial Intelligence | June 21, 2024
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
January 30, 2019 — Magnetic resonance imaging (MRI) provides a safe, noninvasive way to monitor liver fat levels in ...
January 30, 2019 
News | Ultrasound Women's Health
January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission ...
January 30, 2019 
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell imaging agent. The trial will enroll metastatic cancer patients and will study the correlation of imaging signals observed using ImaginAb’s CD8+ T cell ImmunoPET imaging agent, standard-of-care scans and immunohistochemistry analysis of CD8 in biopsied tissues.
January 30, 2019 
Blog | Artificial Intelligence
The odds are good that radiologists want to believe in artificial intelligence (AI). The hype from vendors, professional ...
January 30, 2019 
Feature | Breast Imaging | By Jeff Zagoudis
The importance of early detection of breast cancer has been underscored in recent years as the breast health community ...
January 30, 2019 
Technology | Magnetic Resonance Imaging (MRI)
January 30, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic ...
January 30, 2019 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now